.svg){kind=small}
Jun-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Amend Cannabis has shown a mixed performance across different categories in Missouri. In the Tincture & Sublingual category, the brand maintained a steady rank of 4th place in both March and April of 2024, but saw a slight decline to 5th place in May. Notably, Amend Cannabis did not appear in the top 30 rankings for June, indicating a significant drop in performance or market presence. Despite this, the brand's sales figures in this category show a downward trend from March to May, suggesting potential challenges in maintaining consumer interest or market share.
In the Topical category, Amend Cannabis has demonstrated a more stable performance in Missouri. The brand consistently held the 6th position in March, April, and June of 2024, with a slight dip to 7th place in May. This consistency suggests a reliable consumer base and steady demand for their topical products. Additionally, sales figures in this category show a more balanced trend, with only minor fluctuations between months, highlighting a relatively stable market presence. This performance contrasts with their Tincture & Sublingual category, indicating that Amend Cannabis might have stronger brand loyalty or product effectiveness in the Topical segment.
Competitive Landscape
In the highly competitive Missouri Topical cannabis market, Amend Cannabis has experienced fluctuating rankings over the past few months, indicating a dynamic competitive landscape. In March 2024, Amend Cannabis held the 6th position but dropped to 7th in May, before recovering to 6th place in June. This volatility contrasts with the stable performance of Heartland Labs and Vlasic Labs, which consistently maintained their 4th and 5th ranks, respectively, throughout the same period. Notably, Pharma Girl Cannabis World also exhibited similar fluctuations, often trading places with Amend Cannabis. The entry of Drool into the top 20 in June, debuting at 8th place, adds further competition to an already crowded field. These shifts highlight the importance for Amend Cannabis to innovate and adapt its strategies to maintain and improve its market position amidst strong and stable competitors.
Notable Products
In June 2024, the top-performing product for Amend Cannabis was the CBD/THC 1:1 Amend Tincture (100mg CBD, 100mg THC, 30ml), maintaining its first-place ranking from previous months with a sales figure of 366 units. The CBD/THC 1:1 Amend Infused Balm (50mg CBD, 50mg THC) also retained its consistent second-place ranking. The CBD/THC/CBC 1:1:1 Transdermal Lotion (500mg CBD, 500mg THC, 500mg CBC) held steady in third place, showing an increase in sales from May to June. Meanwhile, the CBD/THC/CBC 1:1:1 Transdermal Lotion (50mg CBD, 50mg THC, 50mg CBC) remained in fourth place, despite a decline in sales. Lastly, the CBD/THC 1:1 Amend Infused Balm (100mg CBD, 100mg THC) continued to rank fifth, with a noticeable drop in sales compared to previous months.
Top Selling Cannabis Brands
